Skip to main content
Clinical Trials/NCT06974630
NCT06974630CompletedNot Applicable

Cervical Erector Spinae Plane Block vs Cervical Plexus Block in Controlling Acute Postoperative Pain After Thyroidectomy: A Randomized Controlled Study

Cairo University1 site in 1 country40 target enrollmentStarted: May 15, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Total morphine consumption

Study Overview

Brief Summary

This study aims to compare the efficacy and safety of cervical erector spinae plane block vs. cervical plexus block in controlling acute postoperative pain after thyroidectomy.

Detailed Description

Thyroidectomy is one of the most commonly performed surgeries in females worldwide, as thyroid disease predominantly affects females with a ratio of 4:1. Thyroid operations can cause mild to moderate incisional pain. It has also been reported that the morphine consumption on the first postoperative day is 90%.

Cervical plexus block, either superficial or deep or combinations given bilaterally, could easily lead to an adequate block appropriate for thyroid surgery without any significant side effects.

Erector spinae plane block (ESPB) is the new favorite among various fascial plane blocks. Local anesthetic drug is injected in the fascial plane superficial to the transverse process and deeper to the erector spinae muscle (ESM).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age from 18 to 65 years.
  • •Both genders.
  • •American Society of Anesthesiologists (ASA) physical status I-II.
  • •Scheduled for either hemi- or total thyroidectomy.

Exclusion Criteria

  • •Known allergy to local anesthetics.
  • •Allergy to all opioid medications.
  • •Pregnant patient.
  • •Previous neck surgery.
  • •Recent use of non-steroidal anti-inflammatory drugs (NSAIDs), opioids or steroid injection within 2 weeks.
  • •Those who cannot utilize the numeric rating scale (NRS) .
  • •Chronic opioid use.
  • •Coagulopathy.

Arms & Interventions

ESPB group

Experimental

Patients will receive bilateral ultrasound-guided cervical erector spinae plane block using 15 ml of bupivacaine 0.25% on each side.

Intervention: Cervical erector spinae plane block (Other)

SCPB group

Active Comparator

Patients will receive bilateral ultrasound-guided superficial cervical block using 15 mL of 0.25% plain bupivacaine on each side of the neck.

Intervention: Cervical plexus block (Other)

Outcomes

Primary Outcomes

Total morphine consumption

Time Frame: 48 hours postoperatively

Rescue analgesia of morphine will be given as 3 mg bolus if the numeric rating scale (NRS) \> 3 to be repeated after 30 min if pain persists until the NRS \< 4.

Secondary Outcomes

  • Degree of pain(48 hours postoperatively)
  • Time to the 1st rescue analgesia(48 hours postoperatively)
  • Intraoperative fentanyl consumption(Intraoperatively)
  • Incidence of adverse events(48 hours postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Elsaid Abdel Fattah

Lecturer of Anesthesia, Surgical ICU and Pain Management, Faculty of Medicine, National Cancer Institute, Cairo University, Egypt.

Cairo University

Study Sites (1)

Loading locations...

Similar Trials